Pill Burden a Key Concern With New Chronic Hepatitis C Drugs - Marketwire (press release)
Pill Burden a Key Concern With New Chronic Hepatitis C DrugsMarketwire (press release)Ribavirin therapy is contraindicated in women who are pregnant and in the male partners of women who are pregnant. Extreme care must be taken to avoid pregnancy during therapy and for 6 months after completion of therapy in both female patients and in ...and more��
Blog Content
Posts
No comments:
Post a Comment